Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × Losartan × Clear all

NCT03563248 2025-10-01

Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT05861336 2024-12-27

OVERPASS

Phase 2 Withdrawn

Gastrointestinal

Pancreatic Neoplasms

NCT01821729 2020-09-25

Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer

Phase 2 Unknown

50 enrolled 11 charts

Gastrointestinal

Pancreatic Neoplasms